Azab AK, Runnels JM, Pitsillides C, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009;113(18):4341-4351

by | Jun 20, 2024 | Publications | 0 comments

Blood. 2024 Jun 20;143(25):2673. doi: 10.1182/blood.2024025275.

NO ABSTRACT

PMID:38900482 | DOI:10.1182/blood.2024025275

Submit a Comment